Healthcare resource utilization and costs among patients with post-stroke spasticity before and after spasticity management including onabotulinumtoxina.

"Conflicts of interest and funding disclosure. AE has served as scientific advisor to and has received research support from Allergan (now AbbVie) and Ipsen. MV-G has been a paid consultant or on an advisory board for AbbVie, Ipsen, Medtronic, and Merz. She has a research grant from Ipsen. LB and KM-W are employees of Curta, Inc, which received financial support from AbbVie for the conduct of this study. DO is an employee of Genesis Research, which received financial support from AbbVie for the conduct of this study. AT is a former employee of AbbVie, currently employed by Curta Consulting, and may hold AbbVie stock. PG is a former employee of AbbVie, currently employed by BioCryst Pharmaceuticals, and may hold AbbVie stock.: This study was sponsored by AbbVie."

"AbbVie funded this study and participated in the study design, research, analysis, data collection, interpretation of data, reviewing, and approval of the publication. All authors had access to relevant data and participated in the drafting, review, and approval of this publication. No honoraria or payments were made for authorship. Medical writing support was provided by Peloton Advantage, LLC, an OPEN Health company, Parsippany, NJ, USA, and was funded by AbbVie. Conflicts of interest and funding disclosure. AE has served as scientific advisor to and has received research support from Allergan (now AbbVie) and Ipsen. MV-G has been a paid consultant or on an advisory board for AbbVie, Ipsen, Medtronic, and Merz. She has a research grant from Ipsen. LB and KM-W are employees of Curta, Inc, which received financial support from AbbVie for the conduct of this study. DO is an employee of Genesis Research, which received financial support from AbbVie for the conduct of this study. AT is a former employee of AbbVie, currently employed by Curta Consulting, and may hold AbbVie stock. PG is a former employee of AbbVie, currently employed by BioCryst Pharmaceuticals, and may hold AbbVie stock.: This study was sponsored by AbbVie."